BioCT

The Bar Harbor, Maine-based nonprofit has exceeded the hiring targets tied to nearly $290 million in state support for its Farmington genomic medicine facility, but Connecticut has yet to receive any royalty payments and direct startup creation has been limited to two spinouts.

A Connecticut biotech industry leader warns that a well-intentioned drug pricing bill could undermine the state's life sciences sector and hurt the very patients it aims to help.

BioCT, the state’s life sciences industry group, is urging state lawmakers to adopt a package of tax, infrastructure and innovation policies in 2026 to help state biotech companies grow and attract talent.

Connecticut's healthcare sector faces rising insurance costs, with rates up 16.8% for individual plans, potential Medicaid cuts affecting 150,000 residents, and the state tapping its rainy day fund to offset federal funding losses.

Connecticut’s biotech sector needs stronger digital-tech training, improved infrastructure and more robust state funding to sustain its...